MS drug hope5th June 2008
Makers of a new drug that allows multiple sclerosis patients to walk more quickly has passed the next step in its testing.
Acorda has tested the drug on 240 patients and found that two-fifths showed signs of improvement and now plans to seek a US safety licence next year. The MS Society in the UK said that the drug frampridine – which is aimed at those who are still capable of walking but find it a difficult process - could have a real impact on the quality of life of some patients.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: MS drug hope
Author: Mark Nicholls
Article Id: 7013
Date Added: 5th Jun 2008